(Q38778053)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

0 references

1 reference

title

Branched-chain amino acids for people with hepatic encephalopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Giulio Marchesini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

7

Hendrik Vilstrup

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Gitte Dam

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Iñigo Les

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Mette Borre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Niels Kristian Aagaard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

18 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

CD001939

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Clinical comparison of branched-chain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Branched-chain amino acids in the treatment of chronic hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Enteral and parenteral branched chain amino acid-supplemented nutritional support in patients with encephalopathy due to alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Dietary management of hepatic encephalopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Minimal hepatic encephalopathy matters in daily life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Review article: the modern management of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

21 January 2018

Hepatic Encephalopathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Acute-on-chronic liver failure: the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Branched-chain amino acids for hepatic encephalopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Imputation methods for missing outcome data in meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Sequential methods for random-effects meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Three targets of branched-chain amino acid supplementation in the treatment of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Diet and cognition in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Nutritional support for liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Minimal hepatic encephalopathy impairs fitness to drive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Decisions about lumping vs. splitting of the scope of systematic reviews of complex interventions are not well justified: a case study in systematic reviews of health care professional reminders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Psychometric tests for diagnosing minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Estimating required information size by quantifying diversity in random-effects model meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Management of hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Branched-chain amino acids for hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Branched-chain amino acids for people with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Branched-chain amino acids for people with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001939.PUB4

Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.

21 January 2018

1 reference

12 December 2020

Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group

1 reference

12 December 2020

Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels

1 reference

12 December 2020

Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis

1 reference

12 December 2020

Assessment of low-grade hepatic encephalopathy: a critical analysis

1 reference

12 December 2020

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver

1 reference

12 December 2020

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis

1 reference

12 December 2020

[Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study]

1 reference

12 December 2020

Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study

1 reference

12 December 2020

Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects

1 reference

12 December 2020

Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial

1 reference

12 December 2020

Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study

1 reference

12 December 2020

Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis

1 reference

12 December 2020

Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study

1 reference

12 December 2020

Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis

1 reference

12 December 2020

Prospective study of nasogastric feeding via East Grinstead or Viomedex tubes compared with oral dietary supplementation in patients with cirrhosis

1 reference

12 December 2020

Cirrhosis, encephalopathy, and improved results with metabolic support

1 reference

12 December 2020

Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients.

1 reference

12 December 2020

Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis

1 reference

12 December 2020

Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

1 reference

12 December 2020

Selective amono acid solutions in hepatic encephalopathy treatment (a preliminary report)

1 reference

12 December 2020

10.1002/14651858.CD001939.PUB4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28518283%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference